ResearchMoz

Pharmaceuticals and Healthcare Market Research Reports & Industry Analysis

The Pharmaceutical Industry is a key segment for global economical growth. While the industry is dominated ...

Pharmaceuticals and Healthcare

Sub Category

Browse reports in Pharmaceuticals and Healthcare

Displaying 4301 to 4330 (of 5433 records)
Pages: « Prev  139 140 141 142 143 144 145 146 147 148   Next »
Zelapar Analysis and Estimates from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Zelapar Analysis and Estimates from 2002 to 2020 provides Zelapar sales estimates for US, and UK. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Parkinson's Disease market....
$2000
Requip (ropinirole) Analysis and Estimates from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Requip (ropinirole) Analysis and Estimates from 2002 to 2020 provides Requip sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Parkinson's...
$2000
Acute Myeloid Leukemia (AML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Acute Myeloid Leukemia (AML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global acute myeloid leukemia (AML) therapeutic market. The report identifies the key trends shaping and driving the global AML therapeutic market. The report...
$2000
Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Post Menopausal Osteoporosis Therapeutics market. The report identifies the key trends shaping and driving the global Post Menopausal Osteoporosis...
$2000
Thalidomide Analysis and Market Forecasts from 2015 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Thalidomide Analysis and Market Forecasts from 2015 to 2020 provides Thalidomide sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Liver...
$2000
Muparfostat Analysis and Market Forecasts from 2017 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Muparfostat Analysis and Market Forecasts from 2017 to 2020 provides Muparfostat sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2017-2020). The report also includes information on Liver...
$2000
Saphris Analysis and Estimates from 2009 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Saphris Analysis and Estimates from 2009 to 2020 provides Saphris sales estimates for US and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Schizophrenia market. This...
$2000
PrevOnco Analysis and Market Forecasts from 2014 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, PrevOnco Analysis and Market Forecasts from 2014 to 2020 provides PrevOnco sales estimates for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Liver Cancer...
$2000
Nexavar Analysis and Market Forecasts from 2007 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Nexavar Analysis and Market Forecasts from 2007 to 2020 provides Nexavar sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Liver...
$2000
Zicronapine Analysis and Forecasts from 2014 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Zicronapine Analysis and Forecasts from 2014 to 2020 provides Zicronapine sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Schizophrenia...
$2000
Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Tyvaso (treprostinil)Analysis and Estimates from 2009 to 2020 provides Tyvaso sales estimates for US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Pulmonary Arterial...
$2000
Geodon Analysis and Forecasts from 2002 to 2017
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Geodon Analysis and Forecasts from 2002 to 2017 provides Geodon sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2017). The report also includes information on Schizophrenia market. This...
$2000
Eldepryl Analysis and Estimates from 2002 to 2012
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Eldepryl Analysis and Estimates from 2002 to 2012 provides Eldepryl sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2012). The report also includes information on Parkinson's Disease...
$2000
Azilect Analysis and Estimates from 2005 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Azilect Analysis and Estimates from 2005 to 2020 provides Azilect sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2005-2020). The report also includes information on Parkinson's Disease...
$2000
Clozapine Analysis and Forecasts from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Clozapine Analysis and Forecasts from 2002 to 2020 provides Clozapinesales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Schizophrenia...
$2000
Risperdal Consta Analysis and Forecasts from 2003 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Risperdal Consta Analysis and Forecasts from 2003 to 2020 provides Risperdal sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2003-2020). The report also includes information on...
$2000
Seroquel Analysis and Estimates from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Seroquel Analysis and Estimates from 2002 to 2020 provides Seroquel sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Schizophrenia...
$2000
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Macitentan (ACT-064992) Analysis and Forecasts from 2013 to 2020 provides Macitentan sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information...
$2000
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Selexipag (ACT-293987, NS-304) Analysis and Forecasts from 2015 to 2020 provides Selexipag sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information...
$2000
Riociguat - Analysis and Forecasts from 2013 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Riociguat Analysis and Forecasts from 2013 to 2020 provides Riociguat sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Pulmonary Arterial...
$2000
Zyprexa Analysis and Forecasts from 2002 to 2018
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Zyprexa Analysis and Forecasts from 2002 to 2018 provides Zyprexa sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2018). The report also includes information on Schizophrenia market....
$2000
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Ventavis (iloprost) Analysis and Estimates from 2003 to 2017 provides Ventavis sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2003-2017). The report also includes information on Pulmonary...
$2000
Abilify Analysis and Estimates from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Abilify Analysis and Estimates from 2002 to 2020 provides Abilify sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Schizophrenia market....
$2000
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Letairis/Volibris (ambrisentan) Analysis and Forecasts from 2007 to 2020 provides Letairis sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information...
$2000
RG1678 Analysis and Forecasts from 2014 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, RG1678 Analysis and Forecasts from 2014 to 2020 provides RG1678 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Schizophrenia market....
$2000
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Revatio (sildenafil)Analysis and Estimates from 2005 to 2020 provides Revatio sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2005-2020). The report also includes information on Pulmonary...
$2000
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Tracleer (bosentan) Analysis and Forecasts from 2002 to 2020 provides Tracleer sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Pulmonary...
$2000
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Veletri (epoprostenol) Analysis and Forecasts from 2010 to 2020 provides Veletri sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on...
$2000
Cariprazine Analysis and Forecasts from 2013 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Cariprazine Analysis and Forecasts from 2013 to 2020 provides Cariprazine sales estimates for US and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Schizophrenia...
$2000
Invega Sustenna Analysis and Forecasts from 2009 to 2020
Jul 2011   |   By - GlobalData
GlobalDatas pharmaceuticals report, Invega Sustenna Analysis and Forecasts from 2009 to 2020 provides Invega Sustenna sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information onSchizophrenia...
$2000
 
Displaying 4301 to 4330 (of 5433 records)
Pages: « Prev  139 140 141 142 143 144 145 146 147 148   Next »